再生医療の世界市場:技術別、地域別

◆英語タイトル:Regenerative Medicine Market by Technology and Geography - Forecast and Analysis 2020-2024
◆商品コード:IRTNTR41171
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年4月2日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Global Regenerative Medicine Market 2020-2024
Technavio has been monitoring the global regenerative medicine market and it is poised to grow by USD 9.55 bn during 2020-2024, progressing at a CAGR of 20% during the forecast period. Our reports on global regenerative medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases.
In addition, increasing number of clinical trials is anticipated to boost the growth of the global regenerative medicine market as well.

Market Segmentation

Technavio’s global regenerative medicine market is segmented as below:
TechnologyCell and tissue-based Gene therapyGeographic segmentationNorth America Europe Asia ROW
Key Trends for global regenerative medicine market growth

This study identifies increasing number of clinical trials as the prime reasons driving the global regenerative medicine market growth during the next few years.

Prominent vendors in global regenerative medicine market

We provide a detailed analysis of around 25 vendors operating in the global regenerative medicine market, including some of the vendors such as Allergan Plc, Amgen Inc., Hitachi Chemical Co. Ltd., Integra LifeSciences Holdings Corp., Medtronic Plc, MiMedx Group Inc., Organogenesis Holdings Inc., Smith & Nephew Plc, Takeda Pharmaceutical Co. Ltd. and Zimmer Biomet Holdings Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/regenerative-medicine-market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Technology
o Market segments
o Comparison by Technology placement
o Cell and tissue-based – Market size and forecast 2019-2024
o Gene therapy – Market size and forecast 2019-2024
o Market opportunity by Technology
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
• Drivers, Challenges, and Trends
o Market drivers
o Volume driver – Demand led growth
o Volume driver – Supply led growth
o Volume driver – External factors
o Volume driver – Demand shift in adjacent markets
o Price driver – Inflation
o Price driver – Shift from lower to higher priced units
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Allergan Plc
o Amgen Inc.
o Hitachi Chemical Co. Ltd.
o Integra LifeSciences Holdings Corp.
o Medtronic Plc
o MiMedx Group Inc.
o Organogenesis Holdings Inc.
o Smith & Nephew Plc
o Takeda Pharmaceutical Co. Ltd.
o Zimmer Biomet Holdings Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
• Exhibits
• 1.Key Finding 1
• 2.Key Finding 2
• 3.Key Finding 3
• 4.Key Finding 4
• 5.Key Finding 5
• 6.Key Finding 6
• 7.Key Finding 7
• 8.Market in focus
• 9.Parent market
• 10.Market characteristics
• 11.Product / Service portfolio of key vendors included in the market definition
• 12.Market segments
• 13.Global – Market size and forecast 2019 – 2024 ($ million)
• 14.Global market: Year-over-year growth 2019 – 2024 (%)
• 15.Five forces analysis 2019 & 2024
• 16.Bargaining power of buyers
• 17.Bargaining power of suppliers
• 18.Threat of new entrants
• 19.Threat of substitutes
• 20.Threat of rivalry
• 21.Market condition – Five forces 2019
• 22.Technology placement – Market share 2019-2024 (%)
• 23.Comparison by Technology placement
• 24.Cell and tissue-based – Market size and forecast 2019-2024 ($ million)
• 25.Cell and tissue-based – Year-over-year growth 2019-2024 (%)
• 26.Gene therapy – Market size and forecast 2019-2024 ($ million)
• 27.Gene therapy – Year-over-year growth 2019-2024 (%)
• 28. Market opportunity by Technology
• 29.Customer landscape
• 30.Market share by geography 2019-2024 (%)
• 31.Geographic comparison
• 32.North America – Market size and forecast 2019-2024 ($ million)
• 33.North America – Year-over-year growth 2019-2024 (%)
• 34.Europe – Market size and forecast 2019-2024 ($ million)
• 35.Europe – Year-over-year growth 2019-2024 (%)
• 36.Asia – Market size and forecast 2019-2024 ($ million)
• 37.Asia – Year-over-year growth 2019-2024 (%)
• 38.ROW – Market size and forecast 2019-2024 ($ million)
• 39.ROW – Year-over-year growth 2019-2024 (%)
• 40.Key leading countries
• 41.Market opportunity by geography ($ million)
• 42.Impact of drivers
• 43.Impact of challenges
• 44.Landscape disruption
• 45.Industry risks
• 46.Vendors covered
• 47.Market positioning of vendors
• 48.Allergan Plc – Overview (1/3)
• 49.Allergan Plc – Overview (2/3)
• 50.Allergan Plc – Overview (3/3)
• 51.Allergan Plc – Business segments
• 52.Allergan Plc – Key offerings
• 53.Allergan Plc – Key customers
• 54.Allergan Plc – Segment focus
• 55.Amgen Inc. – Overview (1/3)
• 56.Amgen Inc. – Overview (2/3)
• 57.Amgen Inc. – Overview (3/3)
• 58.Amgen Inc. – Business segments
• 59.Amgen Inc. – Key offerings
• 60.Amgen Inc. – Key customers
• 61.Amgen Inc. – Segment focus
• 62.Hitachi Chemical Co. Ltd. – Overview (1/3)
• 63.Hitachi Chemical Co. Ltd. – Overview (2/3)
• 64.Hitachi Chemical Co. Ltd. – Overview (3/3)
• 65.Hitachi Chemical Co. Ltd. – Business segments
• 66.Hitachi Chemical Co. Ltd. – Key offerings
• 67.Hitachi Chemical Co. Ltd. – Key customers
• 68.Hitachi Chemical Co. Ltd. – Segment focus
• 69.Integra LifeSciences Holdings Corp. – Overview (1/3)
• 70.Integra LifeSciences Holdings Corp. – Overview (2/3)
• 71.Integra LifeSciences Holdings Corp. – Overview (3/3)
• 72.Integra LifeSciences Holdings Corp. – Business segments
• 73.Integra LifeSciences Holdings Corp. – Key offerings
• 74.Integra LifeSciences Holdings Corp. – Key customers
• 75.Integra LifeSciences Holdings Corp. – Segment focus
• 76.Medtronic Plc – Overview (1/3)
• 77.Medtronic Plc – Overview (2/3)
• 78.Medtronic Plc – Overview (3/3)
• 79.Medtronic Plc – Business segments
• 80.Medtronic Plc – Key offerings
• 81.Medtronic Plc – Key customers
• 82.Medtronic Plc – Segment focus
• 83.MiMedx Group Inc. – Overview (1/3)
• 84.MiMedx Group Inc. – Overview (2/3)
• 85.MiMedx Group Inc. – Overview (3/3)
• 86.MiMedx Group Inc. – Product and service
• 87.MiMedx Group Inc. – Key offerings
• 88.MiMedx Group Inc. – Key customers
• 89.MiMedx Group Inc. – Segment focus
• 90.Organogenesis Holdings Inc. – Overview (1/3)
• 91.Organogenesis Holdings Inc. – Overview (2/3)
• 92.Organogenesis Holdings Inc. – Overview (3/3)
• 93.Organogenesis Holdings Inc. – Business segments
• 94.Organogenesis Holdings Inc. – Key offerings
• 95.Organogenesis Holdings Inc. – Key customers
• 96.Organogenesis Holdings Inc. – Segment focus
• 97.Smith & Nephew Plc – Overview (1/3)
• 98.Smith & Nephew Plc – Overview (2/3)
• 99.Smith & Nephew Plc – Overview (3/3)
• 100.Smith & Nephew Plc – Business segments
• 101.Smith & Nephew Plc – Key offerings
• 102.Smith & Nephew Plc – Key customers
• 103.Smith & Nephew Plc – Segment focus
• 104.Takeda Pharmaceutical Co. Ltd. – Overview (1/3)
• 105.Takeda Pharmaceutical Co. Ltd. – Overview (2/3)
• 106.Takeda Pharmaceutical Co. Ltd. – Overview (3/3)
• 107.Takeda Pharmaceutical Co. Ltd. – Business segments
• 108.Takeda Pharmaceutical Co. Ltd. – Key offerings
• 109.Takeda Pharmaceutical Co. Ltd. – Key customers
• 110.Takeda Pharmaceutical Co. Ltd. – Segment focus
• 111.Zimmer Biomet Holdings Inc. – Overview (1/3)
• 112.Zimmer Biomet Holdings Inc. – Overview (2/3)
• 113.Zimmer Biomet Holdings Inc. – Overview (3/3)
• 114.Zimmer Biomet Holdings Inc. – Product and service
• 115.Zimmer Biomet Holdings Inc. – Key offerings
• 116.Zimmer Biomet Holdings Inc. – Key customers
• 117.Zimmer Biomet Holdings Inc. – Segment focus
• 118.Currency conversion rates for US$
• 119.Research Methodology
• 120.Validation techniques employed for market sizing
• 121.Information sources
• 122.List of abbreviations



【掲載企業】

Allergan Plc
Amgen Inc.
Hitachi Chemical Co. Ltd.
Integra LifeSciences Holdings Corp.
Medtronic Plc
MiMedx Group Inc.
Organogenesis Holdings Inc.
Smith & Nephew Plc
Takeda Pharmaceutical Co. Ltd.
Zimmer Biomet Holdings Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[再生医療の世界市場:技術別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆